Precision BioSciences (DTIL) Tops Q1 EPS by 181c

Precision BioSciences (NASDAQ: DTIL) reported Q1 EPS of $1.70, $1.81 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $17.58 million versus the consensus estimate of $8.83 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Nvidia pitches Vera CPU to Chinese clients with August delivery target